Pearson nurse's drug guide.
Detalles de publicación: New York PearsonDescripción: v. 20 cmISBN:- 9780132149266
- Nurse's drug guide
- RM125 .N78
- QV 39
| Imagen de cubierta | Tipo de ítem | Biblioteca actual | Biblioteca de origen | Colección | Ubicación en estantería | Signatura topográfica | Materiales especificados | Info Vol | URL | Copia número | Estado | Notas | Fecha de vencimiento | Código de barras | Reserva de ítems | Prioridad de la cola de reserva de ejemplar | Reservas para cursos | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Referencia | Biblioteca Encarnación Valdés Sala de Referencia bev | 615.1 P3613 2011 (Navegar estantería(Abre debajo)) | Disponible | 80000002423724 |
Descripciones mejoradas de Syndetics:
With over 310 updates, the new 2011 edition of the Pearson Nurse's Drug Guide provides safe, effective, current, and accurate drug information in a quickly accessible format. Comprehensive and complete, all drugs are listed alphabetically by generic names for quick referral, with an index that includes both generic and trade names. Included are important clinical information for hundreds of drugs including adverse reactions, interactions, and side effects. Find out why this is the only drug guide nurses need: * ONLY handbook to identify prototype drugs * Dosages for neonates, infants, adolescents, adults, and patients with obesity and renal or hepatic impairment * Clearly identified IV preparation and push, continuous, or intermittent administration information * ONLY drug guide to include a glossary of key signs and symptoms for which nurses should monitor during assessment for side effects, interactions, and impact on lab results. ONLY handbook to identify prototype drugs Dosages for neonates, infants, adolescents, adults, and patients with obesity and renal or hepatic impairment Clearly identified IV preparation and push, continuous, or intermittent administration information ONLY drug guide to include a glossary of key signs and symptoms for which nurses should monitor during assessment for side effects, interactions, and impact on lab results.
Authors: 2011- : Billie Ann Wilson, Margaret T. Shannon, Kelly M. Shields.
Title from title page.